期刊文献+

警惕结直肠癌治疗过程中的过度治疗与治疗不足 被引量:4

Precaution of over or under treatment for colorectal cancer
原文传递
导出
摘要 结直肠癌诊疗过程中存在的过度治疗与治疗不足直接影响着患者的预后。结肠和直肠在解剖学上存在明显的区别.导致临床病理分期有所不同。结肠癌和直肠癌辅助治疗的适应证存在一定差异。局部进展期直肠癌应接受新辅助治疗.但目前术前治疗方案存在争议。 Insufficient treatment and overtreatment in the management of colorectal cancer greatly influence patients' outcome. The clinicopathologieal stage of carcinoma located in colon and rectum is different for anatomical differences. The indication of adjuvant chemotherapy varies in colon or rectal cancer. Locally advanced rectal cancer should receive neoadjuvant treatment, however, the optimal regimen is still controversial.
作者 顾晋
出处 《中华胃肠外科杂志》 CAS 北大核心 2011年第8期573-574,共2页 Chinese Journal of Gastrointestinal Surgery
关键词 结直肠肿瘤 过度治疗 治疗不足 Colorectal neoplasms Over treatment Under treatment
  • 相关文献

参考文献5

  • 1Stephen BE, American Joint Committee on Cancer. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York : Springer, 2010 : 718. 被引量:1
  • 2National Comprehensive Cancer Network. Clinical Practice Guidlines of rectal cancer. 2010. http://www.nccn.org/professionals/ physician_gls/PDF/rectal.pdf. 被引量:1
  • 3Wang L, Gu J. Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy. World J Surg, 2010,34 (5): 1080- 1085. 被引量:1
  • 4Gerard JP, Azria D, Geurgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: resuhs of the phase Ⅲ trial ACCORD 12/0405-Prodige 2. J Clin Oncol, 2010,28(10):1638-1644. 被引量:1
  • 5结直肠癌诊疗规范(2010年版)[J].中华胃肠外科杂志,2010,13(11):865-875. 被引量:163

共引文献162

同被引文献26

  • 1徐建明.大肠癌内科治疗现状的认识和评价[J].中华肿瘤杂志,2005,27(12):705-707. 被引量:13
  • 2Grolhey A, Sehmoll HJ. New chemotherapy approaches in coloreetal cancer[ J ]. Curt Opin Oneo1,2001,13 (4) :275-286. 被引量:1
  • 3Stephen BE, David RB, Carolyn CC, et al. A.ICC cancer staging handbook: from the AJCC cancer staging manual [ M ]. 7th ed. New York : Springer, 2010 : 718. 被引量:1
  • 4Christina LK, Hassan SS, Angelique S, et al. Preliminary observations indicate vari- able patterns of plasma 5-fluorouracil (5- FU) levels during dose optimization of in- fusional 5-FU in colorectal cancer pati- ents[J]. Cancer biology & therapy, 2011,12(7):557-568. 被引量:1
  • 5Grimminger PP, Shi M, Barrett C, et aI.TS and ERCC-I mRNA expressions and cli- nical outcome in patients with metastatic colon cancer in CONFIRM-1 and-2 clini- cal trials[J].The plaarmacogenomics jour- nal,2012,12(5):404-411. 被引量:1
  • 6Kim J, Kim YJ, Lee K, et al. Practical out- come of adjuvant folfox4 chemotherapy in elderly patients with stage iii colon can- cer: Single-center study in korea[J]. Japa- nese Joumal of Clinical Oncology,2013, 43(2):132-138. 被引量:1
  • 7Cassidy J, Clarke S, Diaz RE, et al. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results[J]. The British journal of cancer, 2011,105(1):58-64. 被引量:1
  • 8Benson AB,Schrag D,Somerfield MR,et al.American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stageⅡcolon cancer[J].J Clin Oncol,2004,22:3408-3419. 被引量:1
  • 9Wu X,Zhang J,He X,et al.Postoperative adjuvant chemotherapy for stageⅡcolorectal cancer:a systematic review of 12 randomized controlled trials[J].J Gastrointest Surg,2012,16:646-655. 被引量:1
  • 10Andre T,Boni C,Mounedji-Boudiaf L,et al.Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer[J].N Engl J Med,2004,350:2343-2351. 被引量:1

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部